Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
EJNMMI Radiopharmacy and Chemistry|July 20, 2026
Synthesis and in vitro evaluation of pharmacokinetically optimized 99mTc-labeled cholecystokinin-2 receptor-targeted peptides for improved SPECT imagingVeronika Felber, Nadine Holzleitner, Thomas GüntherJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2022
Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo StabilityThomas Günther, Sandra Deiser, Veronika Felber, et al.EJNMMI Research|December 7, 2020
Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokineticsAlexander Wurzer, Mara Parzinger, Matthias Konrad, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate CancerAlexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 30, 2025
First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical TherapyVeronika Felber, Nadine Holzleitner, Markus Joksch, et al.Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2Carolina Giammei, Theresa Balber, Veronika Felber, et al.Pageof 1